🌱 KidneyEnergy.com

← brief for 2026-11-12 · Slowing decline

Colchicine use was associated with reduced all-cause mortality in patients with diabetic gout without prior coronary artery disease: A propensity-matched nationwide cohort study.

Article C Peer reviewed Observational

Key takeaways

This study looked at 17,337 people with diabetes and gout. It found that those taking colchicine had lower death rates. This shows a link, but it is not proof that the drug caused the benefit.

Who did this work

Shin Y (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.) · Cha JJ (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.) · Kim JH (Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.) · Joo HJ (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.) · Park JH (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.) · Yu CW (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.) · Park M (Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, South Korea.) · Lee Y (Department of Data Science, Hanmi Pharm. Co., Ltd, Seoul, South Korea.) · Hong SJ (Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, South Korea.)

Source

Article · Europe PMC, CKD · 2026-11-11
https://doi.org/10.1371/journal.pone.0362218